Investitionsthese
Linc invests in companies that create value and improve quality of life within Life Science, focusing on product-oriented businesses in the Nordic region. Their pharmaceutical investments are typically in early stages, while medical technology investments target more developed companies.
Investitionsphase
Early-stage for pharmaceuticals, more mature for medical technology
Bevorzugte Reifephase für die erste Finanzierung.
Sektoren & Themen
Product-oriented companies in the Nordic Life Science industry, primarily pharmaceutical and medical device companies
Thematische Schwerpunkte und Zielmarktsegmente von Interesse.
Ticketgröße
k.A.
Standard-Finanzierungsbetrag pro Runde.
Outreach & Dossier-Analysen
Verifiziertes E-Mail-Muster
Analysen-Scorecard der Investitionsthese
Unser KI-Analyzer hat Portfolio-Unternehmen gescannt und verifizierte Übereinstimmungen berechnet...